Business Standard

Healthcare index nears all-time high, Sun Pharma zooms

According to Motilal Oswal Financial Services, pharma sector will post 28% year-on-year growth in EBITDA

Related News

Shares of pharmaceutical companies are in limelight with Sun Pharmaceutical Industries, Ipca Laboratories, and Aanjaneya Lifecare are trading at their lifetime highs on the Bombay Stock Exchange (BSE).

The Healthcare index — which tracks the movement of pharma shares on the BSE —the largest gainer among the sectoral indices is up 70 points or 1% at 6,845, trading nears to its lifetime high of 6,871 touched on January 2011.

The index has outperforming by gaining 16.6% year-to-date, compared with 12.5% rise in the benchmark index Sensex.

Sun Pharma Industries is trading higher by 2% at Rs 607, extending its yesterday’s over 2% gain after a favourable verdict from the US Supreme Court in its patent case against Novo Nordisk.

According to Motilal Oswal Financial Services, pharma sector will post 28% year-on-year growth in earnings before interest, taxes, depreciation, and amortization (EBITDA) led by strong performance by Sun Pharma on the back of improvement in the profitability of Taro, and Cadila led by acquisitions, Glenmark Pharma and Torrent Pharma on a low base.

The research firm expects the sector will post a topline growth of 13.5% on year-on-year basis (excluding one-offs) and adjusted profit after tax (PAT) is expected to grow by 12.5% on YoY.

Read more on:   
|
|
|
|
|

Read More

Credit ratings fell the most in three years: CRISIL

According to CRISIL, the Indian arm of Standard & Poor which rates over 9,000 issuers in India, credit ratings have fallen the most in three ...

Recommended for you

Advertisements

Quick Links

Market News

Coal India 10% stake sale fully covered

Investors bid for 662 million shares of Coal India versus the issue size of 631.6 million shares

Sensex ends below 29,200; BSE Bankex down 3%

The 30-share Sensex provisionally ended down by 482 points at 29,199 and the 50-share Nifty slipped 130 points at 8,823.

Strides Arcolab gains on USFDA OKs oral dosage facility at Bangalore

The stock was up 4% at Rs 933 on BSE.

ICICI Bank dips over 5% post Q3 results

At 1445 hours, the stock was down nearly 6% at Rs 358 on National Stock Exchange.

Lupin extends gain on Cabinet nod to hike FII limit cap to 49%

The stock up 2% at Rs 1,580, extending its Thursday's 3% rally, on the government nod to raise the cap of FII to 49%.

 

Back to Top